Cargando…
Neurohormonal Modulation as a Therapeutic Target in Pulmonary Hypertension
The autonomic nervous system (ANS) and renin-angiotensin-aldosterone system (RAAS) are involved in many cardiovascular disorders, including pulmonary hypertension (PH). The current review focuses on the role of the ANS and RAAS activation in PH and updated evidence of potential therapies targeting b...
Autores principales: | García-Lunar, Inés, Pereda, Daniel, Ibanez, Borja, García-Álvarez, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700466/ https://www.ncbi.nlm.nih.gov/pubmed/33266371 http://dx.doi.org/10.3390/cells9112521 |
Ejemplares similares
-
Neurohormonal modulation in pulmonary arterial hypertension
por: Peters, Eva L., et al.
Publicado: (2021) -
Targeting Neurohormonal Activation in Pulmonary Arterial Hypertension: Putting the Puzzle Together
por: Gomez-Arroyo, Jose, et al.
Publicado: (2017) -
Microvesicles and inflammatory markers in an animal model of chronic postcapillary pulmonary hypertension
por: Mendoza Zambrano, Elva Maria, et al.
Publicado: (2023) -
Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension
por: García-Álvarez, Ana, et al.
Publicado: (2016) -
Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial
por: Garcia-Lunar, Ines, et al.
Publicado: (2020)